Genomics BioSci & Tech. Co.,Ltd. (TPEX: 4195)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
19.20
+0.10 (0.52%)
Dec 31, 2024, 3:00 PM CST

Genomics BioSci & Tech. Co.,Ltd. Income Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Revenue
417.04396.14419389.97443.18427.65
Upgrade
Revenue Growth (YoY)
2.85%-5.46%7.45%-12.01%3.63%13.92%
Upgrade
Cost of Revenue
300.39276.23282.99280.04288.16273.32
Upgrade
Gross Profit
116.65119.91136.01109.92155.01154.34
Upgrade
Selling, General & Admin
154.11148.47131.79121.69121.8111.6
Upgrade
Research & Development
70.6256.4335.8817.4722.5629.77
Upgrade
Operating Expenses
219.88201.81169.53138.58148.42145.84
Upgrade
Operating Income
-103.23-81.9-33.52-28.666.68.49
Upgrade
Interest Expense
-5.79-4.79-1.98-1.67-1-1.05
Upgrade
Interest & Investment Income
2.322.090.350.271.171.01
Upgrade
Earnings From Equity Investments
-16.48-19.56-18.88-13.462.89-3.05
Upgrade
Currency Exchange Gain (Loss)
0.640.860.72-1.31-2.44-
Upgrade
Other Non Operating Income (Expenses)
0.630.630.81.050.697.49
Upgrade
EBT Excluding Unusual Items
-121.9-102.67-52.5-43.787.9112.89
Upgrade
Gain (Loss) on Sale of Investments
-39.07-65.29124.76-9.31-6.98-
Upgrade
Gain (Loss) on Sale of Assets
---65.18-4.04-
Upgrade
Other Unusual Items
00.02-0.010-
Upgrade
Pretax Income
-160.97-167.9472.2612.09-3.112.89
Upgrade
Income Tax Expense
-0.130.66--1.654.44
Upgrade
Earnings From Continuing Operations
-160.97-168.0771.612.09-1.458.45
Upgrade
Earnings From Discontinued Operations
-----66.76
Upgrade
Net Income to Company
-160.97-168.0771.612.09-1.4575.21
Upgrade
Minority Interest in Earnings
2.48--6.652.079.73
Upgrade
Net Income
-158.49-168.0771.618.740.6284.94
Upgrade
Net Income to Common
-158.49-168.0771.618.740.6284.94
Upgrade
Net Income Growth
--282.09%2927.14%-99.27%-
Upgrade
Shares Outstanding (Basic)
727163606060
Upgrade
Shares Outstanding (Diluted)
727164606061
Upgrade
Shares Change (YoY)
8.03%11.87%5.12%0.23%-0.47%0.63%
Upgrade
EPS (Basic)
-2.19-2.361.130.310.011.41
Upgrade
EPS (Diluted)
-2.19-2.361.130.310.011.40
Upgrade
EPS Growth
--267.48%3103.13%-99.31%-
Upgrade
Free Cash Flow
-288.02-246.28-115.21-121.35-61.5357.36
Upgrade
Free Cash Flow Per Share
-3.98-3.46-1.81-2.01-1.020.95
Upgrade
Dividend Per Share
--0.098--1.153
Upgrade
Gross Margin
27.97%30.27%32.46%28.19%34.98%36.09%
Upgrade
Operating Margin
-24.75%-20.67%-8.00%-7.35%1.49%1.99%
Upgrade
Profit Margin
-38.00%-42.43%17.09%4.81%0.14%19.86%
Upgrade
Free Cash Flow Margin
-69.06%-62.17%-27.50%-31.12%-13.88%13.41%
Upgrade
EBITDA
-56.83-49.01-5.410.8137.7242.31
Upgrade
EBITDA Margin
-13.63%-12.37%-1.29%0.21%8.51%9.89%
Upgrade
D&A For EBITDA
46.432.8928.129.4731.1233.82
Upgrade
EBIT
-103.23-81.9-33.52-28.666.68.49
Upgrade
EBIT Margin
-24.75%-20.67%-8.00%-7.35%1.49%1.99%
Upgrade
Effective Tax Rate
--0.92%--34.44%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.